X-Linked Retinitis Pigmentosa (XLRP)

Ophthalmology·MeSH: Retinal Degeneration

Prevalence

25.0 / 100K

Incidence

1.5 / 100K/yr

3 drugs in development·2 companies·2 clinical trials

Drug Pipeline by Phase

Compare drugs

agtc-501 vs nsr-rpgragtc-501 vs xlrp product candidate

Frequently asked questions

How many drugs are in development for X-Linked Retinitis Pigmentosa (XLRP)?

BioSniper tracks 3 drugs in development for X-Linked Retinitis Pigmentosa (XLRP) across 2 companies.

How many clinical trials target X-Linked Retinitis Pigmentosa (XLRP)?

There are 2 clinical trials targeting X-Linked Retinitis Pigmentosa (XLRP) tracked by BioSniper.

What is the prevalence of X-Linked Retinitis Pigmentosa (XLRP)?

The estimated prevalence of X-Linked Retinitis Pigmentosa (XLRP) is approximately 25.0 per 100,000 population.

Deep-dive into X-Linked Retinitis Pigmentosa (XLRP)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis